Therapeutic cream for application to skin
AssigneeCore Products International, Inc.
InventorsPhilip H. Mattison, Paul Raymond Norstrem, Robert J. Bard, Michael Artie Warshaw
Life of this patent
Estimating the term…
Abstract
A stable, efficacious therapeutic cream comprising a non-steroidal anti-inflammatory drug (NSAID) is disclosed.
Claims41
An aqueous cream for topical application to the skin comprising about 5% (w/w) to about 15% (w/w) diethylene glycol monoethyl ether, about 4% (w/w) to about 8% (w/w) tropical or vegetable oil, about 3% (w/w) to about 6.5% (w/w) ibuprofen, and about 56% (w/w) to about 68% (w/w) water, wherein said cream is stable at a temperature of 40° C. for a period of at least one month.
A aqueous cream for topical application to the skin comprising greater than about 5% by weight diethylene glycol monoethyl ether, tropical or vegetable oil, an excipient component, ibuprofen, and water, wherein said cream is stable at temperatures of at least 40° C. for a period of at least one month.
An aqueous cream for topical application to the skin comprising tropical or vegetable oil, an excipient component, ibuprofen, water, and diethylene glycol monoethyl ether, wherein said cream is stable at a temperature of 40° C. for a period of at least one month.
An aqueous cream for topical application to the skin comprising tropical or vegetable oil, an excipient component, ibuprofen, water, and means for enhancing topical penetration, wherein said cream is stable at a temperature of 40° C. for a period of at least one month.
A therapeutic cream for application to skin comprising coconut oil, a trigylceride, glycerol, xanthan gum, PEG-6 stearate, ethylene glycol palmitostearate, PEG-32 stearate, diethylene glycol monoethyl ether, phenoxyethanol, propyl paraben, methyl paraben, ibuprofen, and water, wherein said cream is stable at a temperature of 40° C. for a period of at least one month.
Dependencies are inferred from the claim text.